Lu Lanyu, Liu Bowei, Ma Yongfang
Department of Endocrinology and Metabolic Diseases, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Department of Endocrinology, The First Hospital of Qinhuangdao, Qinhuangdao, Hebei, People's Republic of China.
Diabetes Metab Syndr Obes. 2023 Mar 21;16:841-848. doi: 10.2147/DMSO.S398475. eCollection 2023.
To investigate the relationship between different obesity phenotypes and sarcopenia in hospitalized Chinese patients with type 2 diabetes mellitus (T2DM).
This cross-sectional study included 385 men. Anthropometric measurements including applied the determination method of Dual-energy X-ray absorptiometry (DXA) determination of limb skeletal muscle mass index (ASMI) and blood samples were analyzed. The people were divided into four groups according to body mass index (BMI) (≥24kg/m) and waist circumference (WC) (female ≥85cm, male ≥90cm). Group A (BMI and WC were normal), Group B (BMI was normal and high WC), Group C (high BMI and WC were normal), and Group D (BMI and WC were abnormal).
The prevalence rates of sarcopenia and abdominal obesity were 32.2% and 74.0%, respectively. The detection rate of lower ASMI decreased gradually from Group A to Group D(74.6% vs 68.3% vs 54.5% vs 51.6%, χ 2 =14.243, P=0.003). Logistic analysis showed that the risk of lower ASMI were decreased by 62.4% (95% CI: 0.149-0.950, P = 0.039) in Group C and 68.8% (95% CI: 0.165-0.593, P = 0.000) in Group D compared with Group A, respectively. The risk of lower ASMI were increased 4.153-fold (95% CI: 2.623-6.576, P = 0.000) in male. Male (OR = 4.065, 95% CI: 2.246-7.356, P = 0.000) and WC (OR = 1.053, 95% CI: 1.004-1.104, P = 0.033) were risk factors for lower ASMI, but the risk of lower ASMI was decreased by 32% (95% CI: 0.5744-0.804, P = 0.000) by elevated BMI in the overweight and obese group (Group C and Group D).
The prevalence of sarcopenia and abdominal obesity was elevated in han Chinese middle-aged and elderly patients with T2DM. Being overweight or obesity as defined by BMI protect against sarcopenia, while abdominal obesity increases the risk of sarcopenia.
探讨中国住院2型糖尿病(T2DM)患者不同肥胖表型与肌肉减少症之间的关系。
这项横断面研究纳入了385名男性。进行人体测量,包括采用双能X线吸收法(DXA)测定四肢骨骼肌质量指数(ASMI),并对血样进行分析。根据体重指数(BMI)(≥24kg/m)和腰围(WC)(女性≥85cm,男性≥90cm)将研究对象分为四组。A组(BMI和WC均正常)、B组(BMI正常但WC高)、C组(BMI高但WC正常)和D组(BMI和WC均异常)。
肌肉减少症和腹型肥胖的患病率分别为32.2%和74.0%。从A组到D组,ASMI降低的检出率逐渐下降(74.6%对68.3%对54.5%对51.6%,χ2=14.243,P=0.003)。Logistic分析显示,与A组相比,C组ASMI降低的风险降低了62.4%(95%CI:0.149 - 0.950,P = 0.039),D组降低了68.8%(95%CI:0.165 - 0.593,P = 0.000)。男性ASMI降低的风险增加了4.153倍(95%CI:2.623 - 6.576,P = 0.000)。男性(OR = 4.065,95%CI:2.246 - 7.356,P = 0.000)和WC(OR = 1.053,95%CI:1.004 - 1.104,P = 0.033)是ASMI降低的危险因素,但在超重和肥胖组(C组和D组)中,BMI升高使ASMI降低的风险降低了32%(95%CI:0.5744 - 0.804,P = 0.000)。
中国汉族中老年T2DM患者中肌肉减少症和腹型肥胖的患病率升高。BMI定义的超重或肥胖可预防肌肉减少症,而腹型肥胖会增加肌肉减少症的风险。